Sally Howard will become the new deputy commissioner for policy at the FDA on Friday after leaving her post as chief of staff at HHS. She will be replaced at HHS by Andrea Palm, who has been with the department since 2009.
Published in Brief:
|Sr. Regulatory Specialist, Biotech Center of Expertise||
BASF, The Chemical Co.
|San Diego, CA|
|Director of Clinical Research||
Regenesis Biomedical, Inc.
Meridian Health Plan
|Assistant Vice President - Dental Director||